Developing discriminate model and comparative analysis of differentially expressed genes and pathways for bloodstream samples of diabetes mellitus type 2

BMC Bioinformatics

Volumn 15, Issue 17, 2014, Pages

  Liu, Chang ^a   Lu, Lili ^a   Kong, Quan ^a   Li, Yan ^b   Wu, Haihua ^c   Yang, William ^d   Xu, Shandan ^a   Yang, Xinyu ^e   Song, Xiaolei ^a   Yang, Jack Y ^f,g   Yang, Mary Qu ^d   Deng, Youping ^a,b  

^a WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c Department of Ophthalmology and Otorhinolaryngology   (China)

^d UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^e National 48610 Hospital of Armed Police Force   (China)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Differential gene expression; Discriminant model; Gene Ontology (GO) analysis; Pre diabetic; T2D

Indexed keywords

CELL PROLIFERATION; CHROMOSOMES; GENES; INFORMATION USE;

DIABETES MELLITUS TYPE 2; DIFFERENTIAL GENE EXPRESSIONS; DIFFERENTIALLY EXPRESSED GENE; DISCRIMINANT MODELS; DRUG TARGET IDENTIFICATION; GENE EXPRESSION PROFILES; GENE ONTOLOGY; PRE-DIABETIC;

GENE EXPRESSION;

BIOLOGICAL MARKER; MESSENGER RNA;

ADULT; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; HUMAN CHROMOSOME; HUMAN GENOME; IMPAIRED GLUCOSE TOLERANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; SIGNAL TRANSDUCTION; STATISTICAL MODEL;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; MODELS, STATISTICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDIABETIC STATE; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84961572632     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-15-S17-S5     Document Type: Article

References (25)

1. World Health Organization. [ http://www.who.int/diabetes/facts/world_figures/en/index.html ]
2. Centers for Disease Control and Prevention. [ http://www.cdc.gov/diabetes/pubs/pdf/ndfs_20 ]
3. From the Centers for Disease Control and Prevention. [ http://www.cdc.gov/mmwr/preview/M ]
4. Letchuman GR, Wan NW, Wan MW, Chandran LR, Tee GH, Jamaiyah H, Isa MR, Zanariah H, Fatanah I, Ahmad FY: Prevalence of diabetes in the Malaysian National Health Morbidity Survey III 2006. Med J Malaysia. 2010, 65: 180-186.
5. Thorpe LE, Upadhyay UD, Chamany S, Garg R, Mandel-Ricci J, Kellerman S, Berger DK, Frieden TR, Gwynn C: Prevalence and control of diabetes and impaired fasting glucose in New York City. Diabetes Care. 2009, 32: 57-62. 10.2337/dc08-0727.
6. Escobedo J, Buitron LV, Velasco MF, Ramirez JC, Hernandez R, Macchia A, Pellegrini F, Schargrodsky H, Boissonnet C, Champagne BM: High prevalence of diabetes and impaired fasting glucose in urban Latin America: the CARMELA Study. Diabet Med. 2009, 26: 864-871. 10.1111/j.1464-5491.2009.02795.x.
7. Qian Y, Lin Y, Zhang T, Bai J, Chen F, Zhang Y, Luo S, Shen H: The characteristics of impaired fasting glucose associated with obesity and dyslipidaemia in a Chinese population. BMC Public Health. 2010, 10: 139-10.1186/1471-2458-10-139.
8. Herder C, Brunner EJ, Rathmann W, Strassburger K, Tabak AG, Schloot NC, Witte DR: Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study. Diabetes Care. 2009, 32: 421-423. 10.2337/dc08-1161.
9. Herder C, Illig T, Rathmann W, Martin S, Haastert B, Muller-Scholze S, Holle R, Thorand B, Koenig W, Wichmann HE, Kolb H: Inflammation and type 2 diabetes: results from KORA Augsburg. Gesundheitswesen. 2005, 67 (Suppl 1): S115-S121.
10. Kong L, Zhu J, Han W, Jiang X, Xu M, Zhao Y, Dong Q, Pang Z, Guan Q, Gao L: Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 2011, 48: 61-69. 10.1007/s00592-010-0226-0.
11. Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL, Owen K, Davies D, Smith GD, Ben-Shlomo Y: A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes. 2002, 51: 2313-2316. 10.2337/diabetes.51.7.2313.
12. Singh K, Agrawal NK, Gupta SK, Singh K: Association of Variant rs7903146 (C/T) Single Nucleotide Polymorphism of TCF7L2 Gene With Impairment in Wound Healing Among North Indian Type 2 Diabetes Population: A Case-Control Study. Int J Low Extrem Wounds. 2013
13. Reichelt AJ, Spichler ER, Branchtein L, Nucci LB, Franco LJ, Schmidt MI: Fasting plasma glucose is a useful test for the detection of gestational diabetes. Brazilian Study of Gestational Diabetes (EBDG) Working Group. Diabetes Care. 1998, 21: 1246-1249. 10.2337/diacare.21.8.1246.
14. Ealovega MW, Tabaei BP, Brandle M, Burke R, Herman WH: Opportunistic screening for diabetes in routine clinical practice. Diabetes Care. 2004, 27: 9-12. 10.2337/diacare.27.1.9.
15. McCarthy MI, Zeggini E: Genome-wide association studies in type 2 diabetes. Curr Diab Rep. 2009, 9: 164-171. 10.1007/s11892-009-0027-4.
16. Palmer CN: Novel insights into the etiology of diabetes from genome-wide association studies. Diabetes. 2009, 58: 2444-2447. 10.2337/db09-1153.
17. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S: A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007, 445: 881-885. 10.1038/nature05616.
18. Frayling TM: Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet. 2007, 8: 657-662. 10.1038/nrg2178.
19. Zeggini E: A new era for Type 2 diabetes genetics. Diabet Med. 2007, 24: 1181-1186. 10.1111/j.1464-5491.2007.02274.x.
20. Zhao C, Mao J, Ai J, Shenwu M, Shi T, Zhang D, Wang X, Wang Y, Deng Y: Integrated lipidomics and transcriptomic analysis of peripheral blood reveals significantly enriched pathways in type 2 diabetes mellitus. BMC Med Genomics. 2013, 6 (Suppl 1): S12-
21. Sakoda H, Ogihara T, Anai M, Funaki M, Inukai K, Katagiri H, Fukushima Y, Onishi Y, Ono H, Yazaki Y: No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes. Diabetes. 1999, 48: 1365-1371. 10.2337/diabetes.48.7.1365.
22. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP: Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 2002, 30: e15-10.1093/nar/30.4.e15.
23. Grayson BL, Wang L, Aune TM: Peripheral blood gene expression profiles in metabolic syndrome, coronary artery disease and type 2 diabetes. Genes Immun. 2011, 12: 341-351. 10.1038/gene.2011.13.
24. Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y, Heim K, Campillos M, Holzapfel C, Thorand B: Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol. 2012, 8: 615-
25. Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C: Metabolite profiles and the risk of developing diabetes. Nat Med. 2011, 17: 448-453. 10.1038/nm.2307.